PPPP 2026 Congress Highlights Critical Role of Microbiota in Pediatric Health and Long-Term Developmental Outcomes
The PPPP 2026 congress, held in the historic city of Lecce, Italy, concluded with a comprehensive summary of the latest…
The PPPP 2026 congress, held in the historic city of Lecce, Italy, concluded with a comprehensive summary of the latest…
The PPPP 2026 congress, recently concluded in the historic city of Lecce, Italy, has set a new benchmark for the…
A groundbreaking, large-scale analysis of nearly 100,000 individuals has revealed a significant association between the use of glucagon-like peptide-1 (GLP-1)…
The medical community has long recognized Polycystic Ovary Syndrome (PCOS) as the leading endocrine disorder among women of reproductive age,…
Polycystic Ovary Syndrome (PCOS), a complex endocrine disorder affecting an estimated 8% to 13% of women of reproductive age worldwide,…
New research indicates that glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely prescribed for type 2 diabetes and…
Polycystic Ovary Syndrome (PCOS) remains one of the most prevalent endocrine disorders among women of reproductive age, affecting approximately 8%…
Polycystic Ovary Syndrome (PCOS) remains the most prevalent endocrine disorder among women of reproductive age globally, affecting an estimated 8%…
Polycystic Ovary Syndrome (PCOS) represents one of the most prevalent endocrine disorders among women of reproductive age, affecting between 6%…
New research emerging from a collaborative effort between the University of Eastern Finland, the Karolinska Institutet in Stockholm, and Griffith…